Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Evidence Quality Summary Honest appraisal of the evidence hierarchy for this stack: | Claim | Evidence Level | |---|---| | Ipamorelin raises GH via GHSR-1a | Strong: mechanistic + animal + human Phase I | | CJC-1295 raises GH and IGF-1 in humans | Moderate: Phase II RCT (N=65) | | Combination produces synergistic GH pulses | Moderate in animals
The evidence from published intervention trials is consistent: T/T individuals receiving adequate 5-MTHF + B12 + B6 supplementation normalize plasma homocysteine to levels similar to C/C individuals, restore BH4 availability and endothelial function, and reduce the functional consequences of MTHFR impairment across most of the five longevity mechanisms described above
The caution is primarily about MTC and MEN2 risk, not about everyday hypothyroidism or even most other thyroid cancers
Masoud, M
Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know What happens when patients stop taking a GLP-1
Monitoring mental health during the transition to GLP-1 therapy is essential, and any significant mood changes should prompt immediate discussion with a healthcare provider
